IP Library Granted Patent US 10,184,934
Granted Patent B2
US 10,184,934 · App. 15/609,360 · Granted Jan 22, 2019

Multisignal reagents for labeling analytes

Inventors: Jack Coleman (East Northport, NY); Maciej Szczepanik (Mount Sinai, NY); Richard Jin (Pennington, NJ)
Assignee: Enzo Life Sciences, Inc.
G01N33/53C07H21/00C07H21/04C09B11/08C09B11/24C12Q1/6818G01N33/581G01N33/82G01N33/94
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,184,934
App. No.
15/609,360
Granted
Jan 22, 2019
Kind
B2
Abstract

Provided is a composition comprising an analyte bound covalently or through a first binding pair to a polymer. In this composition, the analyte is less than about 2000 MW; the polymer further comprises more than one signal or first member of a second binding pair; and the analyte is not a member of the first binding pair or the second binding pair. Also provided is an assay for an analyte. The assay comprises: combining a sample suspected of containing the analyte with the above-described composition and a binding agent that binds to the analyte; and detecting the signal or the first member of the second binding pair that is bound to the binding agent. Additionally provided is a multisignal labeling reagent comprising a first polymer covalently bound to (a) a reactive group or a first member of a first binding pair, and (b) more than one digoxigenin molecule.

Claims (29)

1. A multisignal labeling reagent comprising:

a first polymer covalently bound to

(a) a reactive group or a first member of a first binding pair, and

(b) more than one digoxigenin molecule; and

bound to each digoxigenin molecule, an anti-digoxigenin antibody that is further bound to at least one signal molecule.

2. The multisignal labeling reagent of claim 1 , wherein each signal is a fluorescent dye, a radioactive molecule or an enzyme.

3. The multisignal labeling reagent of claim 1 , wherein each signal comprises an enzyme selected from the group consisting of alkaline phosphatase, horseradish peroxidase and luciferase.

4. The multisignal labeling reagent of claim 1 , wherein first polymer comprises a first member of a first binding pair, wherein the first binding pair is selected from the group consisting of a sugar-lectin, an antigen-antibody, a ligand-ligand receptor, a hormone-hormone receptor, an enzyme-substrate, a biotin-avidin, and a biotin-streptavidin.

5. The multisignal labeling reagent of claim 4 , wherein the first binding pair is biotin-streptavidin.

6. The multisignal labeling reagent of claim 1 , wherein the polymer comprises a nucleic acid, an abasic nucleic acid, a peptide nucleic acid, a polypeptide, a protein, an oligosaccharide, a polysaccharide or an organic polymer.

7. The multisignal labeling reagent of claim 1 , wherein the polymer is less than about 100 monomers.

8. The multisignal labeling reagent of claim 1 , wherein the polymer is a nucleic acid.

9. The multisignal labeling reagent of claim 8 , wherein the nucleic acid is DNA or comprises at least one nucleotide analog.

10. The multisignal labeling reagent of claim 8 , wherein the nucleic acid is less than about 100 nucleotides and/or nucleotide analogs.

11. The multisignal labeling reagent of claim 8 , wherein the nucleic acid is less than about 50 nucleotides and/or nucleotide analogs.

12. The multisignal labeling reagent of claim 8 , wherein the nucleic acid is less than about 25 nucleotides and/or nucleotide analogs.

13. The multisignal labeling reagent of claim 8 , wherein the nucleic acid is less than about 15 nucleotides and/or nucleotide analogs.

14. The multisignal labeling reagent of claim 8 , wherein the nucleic acid is linear.

15. The multisignal labeling reagent of claim 8 , wherein the nucleic acid is branched.

16. The multisignal labeling reagent of claim 1 , wherein the first polymer comprises a reactive group.

17. The multi signal labeling reagent of claim 16 , wherein the reactive group is isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, mono- or di-halogen substituted pyridine, mono- or di-halogen substituted diazine, maleimide, aziridine, sulfonyl halogen substituted diazine, maleimide, sulfonyl halide, acid halide, hydroxysuccinimide ester, hydroxysulfosuccinimide ester, imido ester, hydrazine, azidonitrophenyl, azide, 3-(2-pyridyl dithio)-proprionamide, glyoxal, aldehyde, mercury salt, or any combination thereof.

18. The multi signal labeling reagent of claim 1 , further comprising a linker moiety covalently linking

the first polymer to the reactive group or first member of the first binding pair and/or

the first polymer to the more than one digoxigenin molecules.

19. The multi signal labeling reagent of claim 1 , wherein the first polymer is further bound to a second polymer, wherein the second polymer further comprises a signal molecule or a first member of a second binding pair.

20. The multisignal labeling reagent of claim 19 , wherein the first polymer is covalently bound to the second polymer.

21. The multisignal labeling reagent of claim 19 , wherein the first polymer is bound to the second polymer through a third binding pair.

22. The multi signal labeling reagent of claim 1 , bound to a target molecule through the reactive group or the first binding pair.

23. The multi signal labeling reagent of claim 22 , wherein the target molecule is a hapten, a protein, an oligopeptide, a nucleic acid, a nucleic acid analog, an oligosaccharide, a polysaccharide, a lipid or an organic polymer.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2017
From: SZCZEPANIK, MACIEJ; COLEMAN, JACK; JIN, RICHARD
To: ENZO LIFE SCIENCES, INC. C/O ENZO BIOCHEM
Reel/Frame 043097/0146 →
Continuity (5)
Division 13556425 · Jul 24, 2012
Continuation In Part 13065101 · Mar 14, 2011
Continuation In Part 12399393 · Mar 6, 2009
Division 10407818 · Apr 3, 2003
Related Publication 20170315113A1 · Nov 2, 2017